Danaher (DHR)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Danaher | DHR | Healthcare | Diagnostics & Research | 78 | 6.6% |
Current Price ( 1/27 4:03PM EST) | $265.98 | |||
CAPS Rating (Rate this stock on CAPS) | ![]() |
|||
Expected Income Statement | ||||
Current Sales | 31,250.0 | |||
Sales Growth Forecast | 6.2% | |||
Net Profit Margin | 24.2% | |||
Projected Shares Outstanding | 715.07 | |||
EPS - Five year Forecast | $14.27 | |||
Average P/E Ratio | 25.0 | |||
Projected Average Price | $356.79 | |||
Price Appreciation (Annualized) | 6.1% | |||
Annual Dividend Yield | 0.5% | |||
Projected Annual Return | 6.6% | |||
Quality | ||||
Financial Strength | 79 | 19.8 | ||
EPS Stability | 71 | 17.7 | ||
Industry Sales Growth Rate | 9.5% | 8.1 | ||
Industry Net Profit Margin | 17.5% | 17.3 | ||
Calculated Quality Rating | 62.9 | |||
Fool CAPS | ||||
Total Players
602
Outperforms
25
Underperforms
All-Stars (137)
135
Outperforms (99%)
2
Underperforms
|
||||
Fundamental Data Updated: 01/06/2023 |